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technique. A sample of 60 patients gave consent to participate in the study. Each group comprised 30 patients. The median age was 43 years (range: 21 to 72) in the foam sclerotherapy group and 43 years (range: 20 to 76) in the surgical group. The proportion of women was 47% in the foam sclerotherapy group and 60% in the surgical group. It was not stated whether some patients refused to participate or were excluded for any reason from the study. In patients with bilateral varicose veins, only the most affected limb was considered.
Study design
This was a prospective, randomised clinical trial that was carried out at a single institution, the outpatient clinic of Ealing Hospital in the UK. Randomisation was based on sealed envelopes. The patients were evaluated at 3 weeks and 3 months after the operation. Two patients in the surgical group did not undergo the intervention (one patient did not want to have the operation, while another patient moved to a different area). Thus, 2 patients were not considered in the surgical group. At the end of the follow-up period, there were 28 patients in the foam sclerotherapy group and 23 patients in the surgical group. Blinding was not performed. The patients were comparable at baseline in terms of their age, gender, and disease characteristics.
Analysis of effectiveness

Effectiveness results
All procedures were completed as intended and no procedure was abandoned due to technical difficulty.
The median time until return to work or back to normal activity was 2 days (range: 0 to 6) in the foam sclerotherapy group and 8 days (range: 5 to 20) in the surgical group, (p<0.001).
Median quality of life decreased from 15.4 to 9.3 (i.e. 43%) in the foam sclerotherapy group and from 26.1 to 14.1 (i.e. 40%) in the surgical group, (p<0.001).
The median duration of treatment was 45 minutes (range: 45 to 60) in the foam sclerotherapy group and 85 minutes (range: 70 to 95) in the surgical group, (p<0.001).
In the postoperative period, few complications arose in either group. No major complications were observed. Four patients (13.3%) in the foam group needed a second session of sclerotherapy for full obliteration of the great saphenous vein system. In the stripping group, 2 patients (7%) needed a further sclerotherapy session for full obliteration of their residual veins. Five patients (17%) in the foam group had developed resolving skin pigmentation and three (10%) had had an episode of self-limited superficial thrombophlebitis. In the surgical group, 2 patients (9%) complained of symptoms suggesting saphenous nerve injury, and one (4%) developed a skin ulcer following liquid injection sclerotherapy for her residual varicose veins.
The median clinical, etiologic, anatomic, pathophysiologic class (used to classify clinical stage) and the median venous clinical severity score (used to assess disease severity) improved in both groups, but the difference between the groups did not achieve statistical significance.
